Table 2 Classification of fusions detected in 61 glioblastoma samples: fusions previously detected in healthy tissue (N = 6) or in cancers (N = 10).

From: In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma

Fusion

Detected in no. samples

Previously described in cancer

Previously described in gliomas

% of all patients

included

Type of fusion

Detected in healthy tissue (N = 45 samples)

KCNMB4::CNOT2

1

No

No

0.72

In-frame

NUP214::TMOD1

1

No

No

0.72

Frame-shifted

PFKFB3::RP11-563J2.2

3

No

No

2.16

Unknown

PID1::DNER

1

No

No

0.72

In-frame

RP1-34H18.1::NAV3

10

No

No

7.2

Unknown

RP11-444D3.1::SOX5

29

No

No

21

Unknown

Detected in cancers (N = 14 samples)

FRS2::KIF5A

1

Yes

GB

0.72

Unknown

EGFR::SEPTIN14

2

Yes

LG & GB

1.44

In-frame

FGFR3::TACC3

3

Yes

LG & GB

2.16

In-frame

CAPZA2::MET

1

Yes

No

0.72

In-frame

CLIC4::SRRM1

2

Yes

No

1.44

In-frame

DPYSL3::JAKMIP2

1

Yes

No

0.72

In-frame

LANCL2::VOPP1

1

Yes

No

0.72

Unknown

R3HDM2::AVIL

1

Yes

No

0.72

Unknown

RAB3IP::BEST3

1

Yes

No

0.72

Frame-shifted

SEC61G::EGFR

1

Yes

No

0.72

In-frame / Frame-shifted

  1. LG low-grade glioma, GB glioblastoma.